Skip to main content

Posts

Showing posts with the label UK-China

Featured Post

Market Daily Report: Bursa Malaysia Ends Lower On Cautious Sentiment

KUALA LUMPUR, May 21 (Bernama) -- Bursa Malaysia ended at its intraday low on Thursday as investor sentiment remained cautious amid ongoing foreign outflows, although the recent weakness may present bargain-hunting opportunities in fundamentally sound blue-chip counters. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) eased 9.33 points, or 0.54 per cent, to 1,708.36, from yesterday’s close of 1,717.69. The benchmark index, which opened 3.74 points higher at 1,721.43, hit an intraday high of 1,722.50 in early trade before losing momentum for the rest of the day. Market breadth was negative, with losers outpacing gainers 656 to 508, while 565 counters were unchanged, 989 untraded and 32 suspended. Turnover fell to 3.49 billion units worth RM3.70 billion compared with 4.15 billion units worth RM4.29 billion on Wednesday.

UK–China Relations Reset as Starmer, Xi Signal New Chapter Backed by AstraZeneca Deal

Quick Summary UK–China ties reset after years of strain US$15b AstraZeneca investment anchors cooperation Trade, visas, and security collaboration announced Human rights and espionage concerns remain unresolved Britain and China signalled a  reset in diplomatic and economic ties  as Prime Minister  Keir Starmer  and President  Xi Jinping  pledged closer cooperation, anchored by a  US$15 billion investment by  AstraZeneca  in China. What Happened During Starmer’s  four-day visit to China  — the first by a UK prime minister in eight years — the two leaders spent nearly  three hours  together in Beijing, holding formal talks and a working lunch at the  Great Hall of the People . Both sides described the meeting as  warm and constructive , agreeing to rebuild ties that have suffered years of strain. Why It Matters AstraZeneca’s US$15 billion China investment  was highlighted as proof of mutual economic benefit B...